Stocks
ResMed (RMD) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 1 194 | 1 340 | 1 340 | 1 693 | 1 600 | 1 698 | ||
| Changes by years, y/y, % | +12% | 0% | +26% | -5% | +13.7% | ||||
ResMed. EBITDA US GAAP, bln rub
ResMed. EBITDA US GAAP, changes, %
ResMed. EBITDA US GAAP, sum by quarters, bln rub
ResMed (RMD) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 456.9 | 374.6 | 429.2 | 458.5 | 436.0 | 1 698 | |
| Changes by years, y/y, % | +33% | +8% | +24% | +37% | +31% | |||
| Changes by quarters, q/q, % | +66% | -18% | +15% | +7% | -5% | |||
